Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge

European Respiratory Journal

Volumn 36, Issue 5, 2010, Pages 1088-1098

  Kiss, L ^a   Schutte H ^c   Padberg, W ^b   Weissmann, N ^b   Mayer, K ^a   Gessler, T ^a   Voswinckel, R ^a   Seeger, W ^a   Grimminger, F ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cyclo oxygenase; Cytochrome P450; Eicosanoids; Human lung; Lipoxygenase; Soluble epoxide hydrolase

Indexed keywords

EPOXYICOSATRIENOIC ACID; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HEMOLYSIN; HYDROXYICOSATETRAENOIC ACID; ICOSANOID; LEUKOTRIENE; PROSTAGLANDIN SYNTHASE; PROSTANOID;

ANIMAL TISSUE; ARTICLE; ELECTROSPRAY; ESCHERICHIA COLI; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LUNG; LUNG EDEMA; MASS SPECTROMETRY; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; VASOCONSTRICTION;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; ARACHIDONIC ACID; CAPILLARY PERMEABILITY; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIDS; EPOXIDE HYDROLASES; ESCHERICHIA COLI PROTEINS; HEMOLYSIN PROTEINS; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; LEUKOTRIENE B4; LEUKOTRIENE E4; LIPOXYGENASE; LUNG; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; PERFUSION; PROSTAGLANDINS; PULMONARY CIRCULATION; RABBITS; VASOCONSTRICTION;

EID: 78449239937     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00000309     Document Type: Article

References (58)

1. Needleman P, Turk J, Jakschik BA, et al. Arachidonic acid metabolism. Annu Rev Biochem 1986; 55: 69-102.
2. Henderson WR Jr. Eicosanoids and lung inflammation. Am Rev Respir Dis 1987; 135: 1176-1185.
3. Grimminger F, Becker G, Seeger W. High yield enzymatic conversion of intravascular leukotriene A4 in blood-free perfused lungs. J Immunol 1988; 141: 2431-2436.
4. Fitzpatrick FA, Murphy RC. Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of "epoxygenase"- derived eicosanoids. Pharmacol Rev 1988; 40: 229-241.
5. Holtzman MJ. Arachidonic acid metabolism. Implications of biological chemistry for lung function and disease. Am Rev Respir Dis 1991; 143: 188-203.
6. Henderson WR Jr. The role of leukotrienes in inflammation. Ann Intern Med 1994; 121: 684-697.
7. Zeldin DC, Plitman JD, Kobayashi J, et al. The rabbit pulmonary cytochrome P450 arachidonic acid metabolic pathway: characterization and significance. J Clin Invest 1995; 95: 2150-2160.
8. Grimminger F, Mayer K, Kiss L, et al. Synthesis of 4- and 5-series leukotrienes in the lung microvasculature challenged with Escherichia coli hemolysin: critical dependence on exogenous free fatty acid supply. Am J Respir Cell Mol Biol 1997; 16: 317-324.
9. Grimminger F, Wahn H, Mayer K, et al. Impact of arachidonic versus eicosapentaenoic acid on exotoxin-induced lung vascular leakage: relation to 4-series versus 5-series leukotriene generation. Am J Respir Crit Care Med 1997; 155: 513-519.
10. Kiss L, Schütte H, Mayer K, et al. Synthesis of arachidonic acid-derived lipoxygenase and cytochrome P450 products in the intact human lung vasculature. Am J Respir Crit Care Med 2000; 161: 1917-1923.
11. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002; 82: 131-185.
12. Peters-Golden M, Henderson WR Jr. Leukotrienes. N Engl J Med 2007; 357: 1841-1854.
13. Palmer RM, Stepney RJ, Higgs GA, et al. Chemokinetic activity of arachidonic and lipoxygenase products on leukocytes of different species. Prostaglandins 1980; 20: 411-418.
14. Doerschuk CM, Downey GP, Doherty DE, et al. Leukocyte and platelet margination within microvasculature of rabbit lungs. J Appl Physiol 1990; 68: 1956-1961.
15. Ermert L, Duncker HR, Rosseau S, et al. Morphometric analysis of pulmonary intracapillary leukocyte pools in ex vivo-perfused rabbit lungs. Am J Physiol 1994; 267: L64-L70.
16. Grimminger F, Dürr U, Seeger W. Ligand-operated synthesis of 4-series and 5-series leukotrienes in human neutrophils: critical dependence on exogenous free fatty acid supply. Mol Pharmacol 1992; 41: 757-766.
17. Grimminger F, Scholz C, Bhakdi S, et al. Subhemolitic doses of Escherichia coli hemolysin evoke large quantities of lipoxygenase products in human neutrophils. J Biol Chem 1991; 266: 14262-14269.
18. Grimminger F, Menger M, Becker G, et al. Potentiation of leukotriene production following sequestration of neutrophils in isolated lungs: indirect evidence for intercellular leukotriene A4 transfer. Blood 1988; 72: 1687-1692.
19. Grimminger F, Kreusler B, Schneider U, et al. Influence of microvascular adherence on neutrophil leukotriene generation. Evidence for cooperative eicosanoid synthesis. J Immunol 1990; 144: 1866-1872.
20. 4. Eur J Biochem 1988; 173: 93-100.
21. Feinmark SJ. Cooperative synthesis of leukotrienes by leukocytes and vascular cells. Ann N Y Acad Sci 1988; 524: 122-132.
22. Vanderhoek JY, Karmin MT, Ekborg SL. Endogenous hydroxyeicosatetraenoic acids stimulate the human polymorphonuclear leukocyte 15-LO pathway. J Biol Chem 1985; 260: 15482-15487.
23. Setty BNY, Stuart MJ. 15-hydroxy-5,8,11,13-eicosatetraenoic acid inhibits human vascular cyclooxygenase. J Clin Invest 1986; 77: 202-211.
24. Zhu D, Bousamra M II, Zeldin DC, et al. Epoxyeicosatrienoic acids constrict isolated pressurized rabbit pulmonary arteries. Am J Physiol Lung Cell Mol Physiol 2000; 278: L335-343.
25. Michaelis UR, Falck JR, Schmidt R, et al. Cytochrome P4502C9-derived epoxyeicosatrienoic acids induce the expression of cyclooxygenase-2 in endothelial cells. Arterioscler Thromb Vasc Biol 2005; 25: 321-326.
26. Randriamboavonjy V, Kiss L, Falck JR, et al. The synthesis of 20- HETE in small porcine coronary arteries antagonizes EDHF-mediated relaxation. Cardiovasc Res 2005; 65: 487-494.
27. Campbell WB, Gebremedhin D, Pratt PF, et al. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 1996; 78: 415-423. (Pubitemid 26072547)
28. Fisslthaler B, Popp R, Kiss L, et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 1999; 401: 493-497. (Pubitemid 29470209)
29. Busse R, Edwards G, Félétou M, et al. EDHF: bringing the concepts together. Trends Pharmacol Sci 2002; 23: 374-380.
30. Sandow SL. Factors, fiction and endothelium-derived hyperpolarizing factor. Clin Exp Pharmacol Physiol 2004; 31: 563-570. (Pubitemid 39329756)
31. Kiss L, Röder Y, Bier J, et al. Direct eicosanoid profiling of the hypoxic lung by comprehensive analysis via capillary liquid chromatography with dual online photodiode array and tandem mass-spectrometric detection. Anal Bioanal Chem 2008; 390: 697-714.
32. Seeger W, Walter H, Suttorp N, et al. Thromboxane-mediated hypertension and vascular leakage evoked by low doses of Escherichia coli hemolysin in rabbit lungs. J Clin Invest 1989; 84: 220-227. (Pubitemid 19170113)
33. Seeger W, Walmrath D, Grimminger F, et al. Adult respiratory distress syndrome: model systems using isolated perfused rabbit lungs. Methods Enzymol 1994; 233: 549-584. (Pubitemid 24177580)
34. Kiss L, Bieniek E, Weissmann N, et al. Simultaneous analysis of 4- and 5-series lipoxygenase and cytochrome P-450 products from different biological sources by reversed-phase high-performance liquid chromatographic technique. Anal Biochem 1998; 261: 16-28. (Pubitemid 28363121)
35. Garcia JGN, Noonan TC, Jubiz W, et al. Leukotrienes and the pulmonary microcirculation. Am Rev Respir Dis 1987; 136: 161-169.
36. Grimminger F, Walmrath D, Birkemeyer RG, et al. Leukotriene and hydroxyeicosatetraenoic acid generation elicited by low doses of Escherichia coli hemolysin in rabbit lungs. Infect Immun 1990; 58: 2659-2663. (Pubitemid 20228253)
37. Grimminger F, Thomas M, Obernitz R, et al. Inflammatory lipid mediator generation elicited by viable hemolysin-forming Escherichia coli in lung vasculature. J Exp Med 1990; 172: 1115-1125. (Pubitemid 20343211)
38. Pokreisz P, Fleming I, Kiss L, et al. Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling. Hypertension 2006; 47: 762-770.
39. Bhakdi S, Mackman N, Menestrina G, et al. The hemolysin of Escherichia coli. Eur J Epidemiol 1988; 4: 135-143.
40. Voelkel NF, Czartolomna J, Simpson J, et al. FMLP causes eicosanoid-dependent vasoconstriction and edema in lungs from endotoxin-primed rats. Am Rev Respir Dis 1992; 145: 701-711.
41. Abernathy VJ, Webster RO, Dahms TE. C-reactive protein inhibits increased pulmonary vascular permeability induced by fMLP in isolated rabbit lungs. Am J Physiol 1996; 271: H507-H513.
42. Tanaka H, Bradley JD, Baudendistel LJ, et al. Mechanisms of increased pulmonary microvascular permeability induced by FMLP in isolated rabbit lungs. J Appl Physiol 1992; 73: 2074-2082.
43. Palmer RMJ, Salmon JA. Release of leukotriene B4 from human neutrophils and its relationship to degranulation induced by N-formyl- methionyl-leucyl- phenylalanine, serum-treated zymosan and the ionophore A23187. Immunology 1983; 50: 65-73.
44. Bertram TA, Overby LH, Danilowicz R, et al. Pulmonary intravascular macrophages metabolize arachidonic acid in vitro. Am Rev Respir Dis 1988; 138: 936-944.
45. Rose F, Kiss L, Grimminger F, et al. E. coli hemolysin-induced lipid mediator metabolism in alveolar macrophages: impact of eicosapentaenoic acid. Am J Physiol Lung CellMol Physiol 2000; 279: L100-L109.
46. Samuelsson B, Dahlen SE, Lindgren JA, et al. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987; 237: 1171-1176.
47. Juergens UR, Christiansen SC, Stevenson DD, et al. Inhibition of monocyte leukotriene B4 production after aspirin desensitization. J Allergy Clin Immunol 1995; 96: 148-156.
48. Jakobsson PJ, Shaskin P, Larsson P, et al. Studies on the regulation and localization of 5-lipoxygenase in human B-lymphocytes. Eur J Biochem 1995; 232: 37-46.
49. Jakobsson PJ, Odlander B, Claesson HE. Effects of monocytelymphocyte interaction on the synthesis of leukotriene B4. Eur J Biochem 1991; 196: 395-400.
50. Nadeau M, Fruteau de Laclos B, Picard S, et al. Studies on leukotriene B4 v-oxidation in human leukocytes. Can J Biochem Cell Biol 1984; 62: 1321-1326.
51. Hunter JA, Finkbeiner WE, Nadel JA, et al. Predominant generation of 15-lipoxygenasemetabolites of arachidonic acid by epithelial cells from human trachea. Proc Natl Acad Sci USA 1985; 82: 4633-4637.
52. Ingerman-Wojenski C, Silver MJ, Smith JB, et al. Bovine endothelial cells in culture produce thromboxane as well as prostacyclin. J Clin Invest 1981; 67: 1292-1296.
53. Nüsing R, Lesch R, Ullrich V. Immunohistochemical localization of thromboxane synthase in human tissues. Eicosanoids 1990; 3: 53-58.
54. Bizios R, Lai L, Fenton JW 2nd, et al. Thrombin-induced thromboxane generation by neutrophils and lymphocytes: dependence on enzymic site. J Cell Physiol 1987; 132: 359-62. (Pubitemid 17151493)
55. Keserü B, Barbosa-Sicard E, Popp R, et al. Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response. FASEB J 2008; 22: 4306-4315.
56. Wang MH, Brand-Schieber E, Zand BA, et al. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors. J Pharmacol Exp Ther 1998; 284: 966-973. (Pubitemid 28130824)
57. Alvarez DF, Gjerde EAB, Townsley MI. Role of EETs in regulation of endothelial permeability in rat lung. Am J Physiol Lung Cell Mol Physiol 2004; 286: 445-451.
58. Ivey CL, Stephenson AH, Townsley MI. Involvement of cytochrome P-450 enzyme activity in the control of microvascular permeability in canine lung. Am J Physiol Lung Cell Mol Physiol 1998; 275: L756-L763. (Pubitemid 28491858)